These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35357725)

  • 21. Chronic inflammatory neuropathies and their impact on activities and participation.
    Wonink HA; Kruithof WJ; Goedee HS; Beelen A
    Eur J Neurol; 2023 Jul; 30(7):1928-1936. PubMed ID: 37038272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy.
    Jomier F; Bousson V; Viala K; Péréon Y; Magot A; Cauquil C; Bouhour F; Vial C; Bedat-Millet AL; Taithe F; Bresch S; Siri A; Kubis N; Lozeron P
    Eur J Neurol; 2020 Jan; 27(1):181-187. PubMed ID: 31348848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrences, vaccinations and long-term symptoms in GBS and CIDP.
    Kuitwaard K; Bos-Eyssen ME; Blomkwist-Markens PH; van Doorn PA
    J Peripher Nerv Syst; 2009 Dec; 14(4):310-5. PubMed ID: 20021573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inflammatory demyelinating polyneurophaty: assessment of the cognitive function and quality of life.
    Kozow L; Pupe C; Nascimento OJM
    Arq Neuropsiquiatr; 2022 Dec; 80(12):1246-1253. PubMed ID: 36580963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric longitudinal evaluation of the Chronic Acquired Polyneuropathy Patient-Reported Index (CAPPRI) in patients with chronic inflammatory demyelinating polyneuropathy.
    Sadjadi R; Peric S; Gwathmey K; Bozovic I; Aleksa P; Bjelica B; Burns T; Basta I
    Muscle Nerve; 2021 Jan; 63(1):84-88. PubMed ID: 33043466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies.
    Falzone YM; Campagnolo M; Bianco M; Dacci P; Martinelli D; Ruiz M; Bocci S; Cerri F; Quattrini A; Comi G; Benedetti L; Giannini F; Lauria G; Nobile-Orazio E; Briani C; Fazio R; Riva N
    J Neurol; 2018 Dec; 265(12):2927-2933. PubMed ID: 30306264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal nerve fiber involvement in chronic inflammatory demyelinating polyneuropathy.
    Keskiner-Ozturk E; Akkaya-Turhan S; Toker E; Uluc K; Alibas H; Tanridag T; Kahraman-Koytak P
    Neurol Sci; 2023 Jul; 44(7):2509-2516. PubMed ID: 36856905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years.
    Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S
    J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
    Lawley A; Seri S; Rajabally YA
    Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies.
    Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S
    Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy.
    Westblad ME; Forsberg A; Press R
    Disabil Rehabil; 2009; 31(9):720-5. PubMed ID: 19034780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany.
    Mengel D; Fraune L; Sommer N; Stettner M; Reese JP; Dams J; Glynn RJ; Balzer-Geldsetzer M; Dodel R; Tackenberg B
    Muscle Nerve; 2018 Nov; 58(5):681-687. PubMed ID: 30073683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy.
    Grüter T; Motte J; Fisse AL; Bulut Y; Köse N; Athanasopoulos D; Otto S; Yoon MS; Schneider-Gold C; Gold R; Pitarokoili K
    Eur J Neurol; 2020 Dec; 27(12):2595-2603. PubMed ID: 32794258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy.
    Chiò A; Cocito D; Bottacchi E; Buffa C; Leone M; Plano F; Mutani R; Calvo A;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1349-53. PubMed ID: 17494979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative value and determinants of suitability of outcome measures in treated chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Ghasemi M
    Muscle Nerve; 2020 Feb; 61(2):182-186. PubMed ID: 31650551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.
    Fisse AL; Fiegert S; Stoykova Z; Brünger J; Athanasopoulos D; Grüter T; Motte J; Gold R; Pitarokoili K
    Eur J Neurol; 2021 May; 28(5):1698-1705. PubMed ID: 33404183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient perceptions of outcome measures in chronic inflammatory demyelinating polyneuropathy: A study of the Inflammatory Rasch-built Overall Disability Scale.
    White D; Englezou C; Rajabally YA
    Eur J Neurol; 2021 Aug; 28(8):2596-2602. PubMed ID: 33969583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.